The drug also blocks the activin type II receptors on fat cells, and this action appears to reduce fat mass, says Steven Heymsfield, an obesity and body-composition expert at Pennington Biomedical Research Center in Louisiana
11) Emcure Pharmaceuticals - Quietly Crossing the $1 Billion Mark Emcure crossed $1 billion in revenue for the first time in FY26, a significant milestone for a company that has been building a diversified formulations business across India and international markets
The most common lipo C side effects are injection site reactions (redness, swelling, mild bruising) occurring in 2535% of users, gastrointestinal upset (nausea, bloating, diarrhea) in 1520% of users during the first week, and transient flushing or warmth in 812% of users within 30 minutes post-injection
Explore some common challenges affecting your patients, including those using GLP-1s